Yusuke Kiyoura
Koriyama, 9638611, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Candida Infections: The Role of Saliva in Oral Health-A Narrative Review.
Journal: Microorganisms
Published: February 25, 2025
Pretreatment with alendronate augments lipid A-induced IFN-β production via upregulation of cGAS expression.
Journal: Pharmacological reports : PR
Published: December 31, 2024
Synergistic effect of Toll-like receptor 2 ligands and alendronate on proinflammatory cytokine production in mouse macrophage-like RAW-ASC cells is accompanied by upregulation of MyD88 expression.
Journal: Journal of oral biosciences
Published: December 11, 2023
Alendronate augments lipid A‑induced IL‑1β release by ASC‑deficient RAW264 cells via AP‑1 activation.
Journal: Experimental and therapeutic medicine
Published: June 17, 2023
Comparative Pan-Genome Analysis of Oral Veillonella Species.
Journal: Microorganisms
Published: June 30, 2021
Complete Genome Sequence of Veillonella nakazawae JCM 33966T (=CCUG 74597T), Isolated from the Oral Cavity of Japanese Children.
Journal: Microbiology resource announcements
Published: April 30, 2021
Alendronate Augments Lipid A-Induced IL-1α Release via Activation of ASC but Not Caspase-11.
Journal: Inflammation
Published: February 23, 2021
Veillonella nakazawae sp. nov., an anaerobic Gram-negative coccus isolated from the oral cavity of Japanese children.
Journal: International journal of systematic and evolutionary microbiology
Published: December 02, 2020
Etidronate down-regulates Toll-like receptor 2 ligand-induced chemokine production by inhibiting MyD88 expression and NF-κB activation.
Journal: Immunopharmacology and immunotoxicology
Published: November 30, 2020
RANK-RANKL signaling upregulates Il-10 mRNA expression in mucosal Candida infection in vivo.
Journal: Microbial pathogenesis
Published: February 21, 2020
MPMBP down-regulates Toll-like receptor (TLR) 2 ligand-induced proinflammatory cytokine production by inhibiting NF-κB but not AP-1 activation.
Journal: International immunopharmacology
Published: July 01, 2019
Last Updated: 09/26/2026